US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lantern Pharma Inc.

3.11

-0.3100-9.06%

Volume:35.61K

Turnover:111.69K

Market Cap:33.54M

PE:-1.61

High:3.41

Open:3.41

Low:3.00

Close:3.42

Loading ...

Overview Company News Filings

Lantern Pharma initiated with a Buy at Lake Street

LTRN: 2024 Financial Results

Zacks Small Cap Research

Lantern Pharma Inc Qtrly EPS $-0.54

Lantern Pharma Inc reports results for the quarter ended December 31 - Earnings Summary

Lantern Pharma Reports Q4 2024 Financial Results and AI Progress

Lantern Pharma Q4 2024 GAAP EPS $(0.54) Misses $(0.51) Estimate

Lantern Pharma Inc Qtrly EPS $-0.54

THOMSON REUTERS

Lantern Pharma reports Q4 EPS (54c) vs (39c) last year

Press Release: Lantern Pharma Provides Business Updates and Fourth Quarter & Year-End 2024 Financial Results

Press Release: Lantern Pharma to Report Fourth Quarter and Fiscal Year 2024 Operating & Financial Results on March 27th, 2025 at 4:30 p.m. ET

Lantern Pharma to Report Fourth Quarter and Fiscal Year 2024 Operating & Financial Results on March 27TH, 2025 at 4:30 P.m. Et

THOMSON REUTERS

LTRN: M&A Illuminates GBM Value

Zacks Small Cap Research

Lantern Pharma Announces PCT Patent Application Publication for Innovative, High Performing, Machine Learning Model for Predicting Blood Brain Barrier Permeability of Drug-Candidates

Lantern Pharma Inc. (LTRN) Enhances RADR® AI Platform to Accelerate Development of Antibody-Drug Conjugates (ADCs) for Targeted Cancer Therapies

Lantern Pharma : Announces Advancements in Application of Co's Radr AI Platform to Accelerate Development of Antibody-Drug Conjugates for Cancer

THOMSON REUTERS

Lantern Pharma Unveils Innovative AI-Powered Module to Improve the Precision, Cost and Timelines of Antibody-Drug Conjugate (ADC) Development for Cancer

Lantern Pharma Extends CSO’s Employment Agreement

AI-Powered Cancer Solutions: Lantern Pharma (LTRN) Launches Phase 2 Trial in Taiwan

Lantern Pharma Announces First Patient Enrolled in Taiwan for Phase 2 Harmonic™ Clinical Trial of Lp-300 in Never-Smoker Nsclc Patients

THOMSON REUTERS

Lantern Pharma Announces First Patient Enrolled in Taiwan for Phase 2 HARMONIC™ Clinical Trial of LP-300 in Never-Smoker NSCLC Patients

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LTRN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LTRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LTRN\",,,,,undefined,":{"symbol":"LTRN","market":"US","secType":"STK","nameCN":"Lantern Pharma Inc.","latestPrice":3.11,"timestamp":1745265600000,"preClose":3.42,"halted":0,"volume":35612,"delay":0,"floatShares":7963676,"shares":10784725,"eps":-1.930923,"marketStatus":"Pre-Mkt","change":-0.31,"latestTime":"04-22 04:22:06 EDT","open":3.41,"high":3.41,"low":3,"amount":111692.550888,"amplitude":0.119883,"askPrice":4.97,"askSize":200,"bidPrice":2.79,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-1.930923,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745328600000},"marketStatusCode":1,"adr":0,"listingDate":1591848000000,"exchange":"NASDAQ","adjPreClose":3.11,"postHourTrading":{"tag":"盘后","latestPrice":3.11,"preClose":3.11,"latestTime":"17:06 EDT","volume":120,"amount":372.24,"timestamp":1745269605280},"volumeRatio":0.6652071887947901,"impliedVol":2.4351,"impliedVolPercentile":0.9759},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LTRN\",,,,,undefined,":{"symbol":"LTRN","floatShares":7963676,"roa":"-40.12%","roe":"-66.93%","lyrEps":-1.930923,"volumeRatio":0.6652071887947901,"shares":10784725,"dividePrice":0,"high":3.41,"amplitude":0.119883,"preClose":3.42,"low":3,"week52Low":2.55,"pbRate":"1.58","week52High":7.21,"institutionHeld":0,"latestPrice":3.11,"committee":-0.333333,"eps":-1.930923,"divideRate":0,"volume":35612,"delay":0,"ttmEps":-1.930923,"open":3.41,"prevYearClose":3.19,"prevWeekClose":3.42,"prevMonthClose":3.54,"prevQuarterClose":3.54,"fiveDayClose":3.21,"twentyDayClose":3.82,"sixtyDayClose":4.17},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LTRN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524249684","title":"Lantern Pharma initiated with a Buy at Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2524249684","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524249684?lang=en_us&edition=fundamental","pubTime":"2025-04-02 20:47","pubTimestamp":1743598021,"startTime":"0","endTime":"0","summary":"Lake Street initiated coverage of Lantern Pharma (LTRN) with a Buy rating and $25 price target Lantern’s Response Algorithm for Drug Positioning an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lantern-pharma-initiated-with-a-buy-at-lake-street?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lantern-pharma-initiated-with-a-buy-at-lake-street?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LTRN"],"gpt_icon":0},{"id":"2522501367","title":"LTRN: 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522501367","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522501367?lang=en_us&edition=fundamental","pubTime":"2025-03-28 18:20","pubTimestamp":1743157200,"startTime":"0","endTime":"0","summary":"Lantern Pharma, Inc  reports 2024 results highlighting several achievements including progress on its HARMONIC, LP-184 and LP-284 trials, a portfolio of expedited designations in multiple indications and advances in the RADR platform with modules that offer predictive algorithms for blood brain barrier  penetration and antibody drug conjugate  design.On March 27th, 2025, Lantern announced 2024 financial and operational results, filed its Form 10-K with the SEC and hosted a video webcast to review accomplishments. A slide deck was included to guide the discussion. In the financial sphere, Lantern generated no revenues in 2024 and incurred operating expense of $22.2 million, producing a net loss of  million or  per share.General & administrative expenses were $6.1 million, rising 2% from $6.0 million. Higher professional fees were partially offset by lower wage and benefit costs, a decrease in insurance expense and a decline in stock","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ltrn-2024-financial-results-102000980.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TSYW.SI","BK4583","USJW.SI","USAW.SI","BK4080","LTRN","LU0889565916.HKD","NQmain","LU0109394709.USD","ADC","IE00BN0W2T93.GBP",".IXIC","TQQQ","BK4532","QLD","BK4231","NVIW.SI","SQQQ","IE00BN0W2W23.USD","BK4533","IE00BN0W2V16.EUR","JAZZ","LU0823416689.USD","QID","CMRX","BK4139","MNQmain","BK4007","LU0320765992.SGD","PSQ"],"gpt_icon":1},{"id":"2522309537","title":"Lantern Pharma Inc Qtrly EPS $-0.54","url":"https://stock-news.laohu8.com/highlight/detail?id=2522309537","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522309537?lang=en_us&edition=fundamental","pubTime":"2025-03-28 05:12","pubTimestamp":1743109969,"startTime":"0","endTime":"0","summary":"March 27 (Reuters) - Lantern Pharma Inc ::*LANTERN PHARMA INC QTRLY EPS $-0.54  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 27-MAR-202520:01:00.123 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nRSD9W4BY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN"],"gpt_icon":0},{"id":"2522321585","title":"Lantern Pharma Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2522321585","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522321585?lang=en_us&edition=fundamental","pubTime":"2025-03-28 05:00","pubTimestamp":1743109253,"startTime":"0","endTime":"0","summary":"Lantern Pharma Inc reports results for the quarter ended December 31 - Earnings SummaryLantern Pharma Inc LTRN.OQ reported a quarterly adjusted loss of 54 cents per share for the quarter ended Decembe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nL5N3QA25D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN"],"gpt_icon":0},{"id":"2522534161","title":"Lantern Pharma Reports Q4 2024 Financial Results and AI Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2522534161","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522534161?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:35","pubTimestamp":1743107722,"startTime":"0","endTime":"0","summary":"Lantern Pharma ( ($LTRN) ) has issued an announcement. On March 27, 2025, Lantern Pharma announced its financial results for the fourth quarter and...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lantern-pharma-reports-q4-2024-financial-results-and-ai-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lantern-pharma-reports-q4-2024-financial-results-and-ai-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LTRN","LU2065732104.USD","BK4097","PRGS","BK4139"],"gpt_icon":0},{"id":"2522312455","title":"Lantern Pharma Q4 2024 GAAP EPS $(0.54) Misses $(0.51) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2522312455","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522312455?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:28","pubTimestamp":1743107339,"startTime":"0","endTime":"0","summary":"Lantern Pharma (NASDAQ:LTRN) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.51) by 5.88 percent. This is a 38.46 percent decrease over losses of $(0.39) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44524498/lantern-pharma-q4-2024-gaap-eps-0-54-misses-0-51-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN"],"gpt_icon":0},{"id":"2522531388","title":"Lantern Pharma Inc Qtrly EPS $-0.54","url":"https://stock-news.laohu8.com/highlight/detail?id=2522531388","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522531388?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:18","pubTimestamp":1743106711,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nFWN3QA1MY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LTRN"],"gpt_icon":0},{"id":"2522853160","title":"Lantern Pharma reports Q4 EPS (54c) vs (39c) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2522853160","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522853160?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:06","pubTimestamp":1743105964,"startTime":"0","endTime":"0","summary":"“With three clinical precision oncology programs actively enrolling patients and critical data milestones on the horizon, we are at the forefront o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lantern-pharma-reports-q4-eps-54c-vs-39c-last-year?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lantern-pharma-reports-q4-eps-54c-vs-39c-last-year?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LTRN"],"gpt_icon":0},{"id":"2522365539","title":"Press Release: Lantern Pharma Provides Business Updates and Fourth Quarter & Year-End 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522365539","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522365539?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:01","pubTimestamp":1743105660,"startTime":"0","endTime":"0","summary":"-- HARMONIC trial lead-in cohort delivered impressive 86% clinical. benefit rate and 43% objective response rate in never-smoker NSCLC. patients, with current expansion cohort reinforcing these positive trends. as enrollment accelerates in Japan and Taiwan, where 33-40% of NSCLC. cases occur in never-smokers, positioning Lantern for multiple clinical. -- LP-184 received two U.S. FDA Fast Track Designations in 2024 for. Glioblastoma and Triple Negative Breast Cancer, plus three additional. potential across multiple high-need indications with multi billion U.S.-- Successfully dosed multiple patient cohorts in Phase 1A clinical trials. for both LP-184 and LP-284, advancing these synthetic lethal drug. candidates toward drug concentration levels that may show therapeutic. efficacy in several cancers of high unmet patient need and with multiple. immunologically \"cold\" tumors into \"hot\" tumors by reshaping the tumor. Scientific Advisory Board from Johns Hopkins, UCSF, and Memorial Sloan. pro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","LTRN","ML","BK4166","BK4099","BK4232","BK4555","BK4585","R","03160","BK4139","BK4604","BK4588","TM"],"gpt_icon":0},{"id":"2520537134","title":"Press Release: Lantern Pharma to Report Fourth Quarter and Fiscal Year 2024 Operating & Financial Results on March 27th, 2025 at 4:30 p.m. ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2520537134","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520537134?lang=en_us&edition=fundamental","pubTime":"2025-03-20 20:02","pubTimestamp":1742472120,"startTime":"0","endTime":"0","summary":"Lantern Pharma to Report Fourth Quarter and Fiscal Year 2024 Operating & Financial Results on March 27th, 2025 at 4:30 p.m. ET. -- Webcast to be held Thursday, March 27th, 4:30 p.m. ET, register for the. webcast here, or at the link provided below.Lantern Pharma Inc. , an artificial intelligence  company developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning  platform with multiple clinical stage drug programs, today announced that it will host its fourth quarter and fiscal year 2024 operating and financial results webcast on Thursday, March 27, 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time.Our lead development programs include a Phase 2 clinical program and multiple Phase 1 clinical trials. We have also established a wholly-owned subsidiary, Starlight Therapeutics, to focus exclusively on the clinical execution of our promising therapies for CNS and brain cancers, many of which have no effective treatment options. Our AI-driven pip","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN","ET"],"gpt_icon":0},{"id":"2520453183","title":"Lantern Pharma to Report Fourth Quarter and Fiscal Year 2024 Operating & Financial Results on March 27TH, 2025 at 4:30 P.m. Et","url":"https://stock-news.laohu8.com/highlight/detail?id=2520453183","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520453183?lang=en_us&edition=fundamental","pubTime":"2025-03-20 20:00","pubTimestamp":1742472003,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUA2CF2GR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2518010224","title":"LTRN: M&A Illuminates GBM Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2518010224","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518010224?lang=en_us&edition=fundamental","pubTime":"2025-03-10 17:28","pubTimestamp":1741598880,"startTime":"0","endTime":"0","summary":"Lantern Pharma, Inc  continues to enroll its HARMONIC trial for LP-300 at sites around the globe with the most recent focus on Taiwan and Japan, where the prevalence of never-smoker non-small cell lung cancer  is from two to three times higher than in the United States. Lantern’s RADR  platform continues to break ground with new capabilities in predicting blood brain barrier  permeability of drug candidates and improving the development of antibody drug conjugate  design. Lantern’s LP-184 gains another Fast Track designation for triple negative breast cancer  following the receipt of the same designation for glioblastoma last October. The company also angled a spotlight towards its STAR-001  program at the Society for Neuro-Oncology  2024 conference. The associated poster provided support for the combination of spironolactone with the next-generation acylfulvene in glioblastoma multiforme  and clarified the path forward for STAR-001 with the candidate’s trial design. GBM also made an a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ltrn-m-illuminates-gbm-value-092800196.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVIW.SI","NQmain","USAW.SI","BK4007","BK4583","SQQQ","QID","TSYW.SI","JAZZ","IE00BN0W2V16.EUR","BK4090","QLD","IE00BN0W2T93.GBP","USJW.SI","CNS","LU0823416689.USD","BK4231","BK4533","PSQ","BK4139","LU0320765992.SGD","BK4135","IE00BN0W2W23.USD","LTRN","PCT","QQQ","BK4080","BK4532",".IXIC","LU0109394709.USD","CMRX","LU0889565916.HKD","ADC","TQQQ","MNQmain"],"gpt_icon":0},{"id":"2512040061","title":"Lantern Pharma Announces PCT Patent Application Publication for Innovative, High Performing, Machine Learning Model for Predicting Blood Brain Barrier Permeability of Drug-Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2512040061","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512040061?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:00","pubTimestamp":1739970000,"startTime":"0","endTime":"0","summary":"DALLAS, February 19, 2025----Lantern Pharma Inc. , an artificial intelligence  company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development, today announced the publication of its PCT patent application  covering a novel machine learning solution for predicting blood-brain barrier  permeability. The application received a favorable PCT search report indicating no significant prior art, substantially strengthening its path to approval.Lantern's wholly-owned subsidiary, Starlight Therapeutics, intends to implement this technology to advance the development of STAR-001 and evaluate additional drug candidates. In addition, Lantern is actively expanding the system's capabilities through the development of soph","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lantern-pharma-announces-pct-patent-130000045.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4166","LTRN","ML","BK4080","PCT","BK4139","BK4090","BK4231","ADC"],"gpt_icon":0},{"id":"2506558534","title":"Lantern Pharma Inc. (LTRN) Enhances RADR® AI Platform to Accelerate Development of Antibody-Drug Conjugates (ADCs) for Targeted Cancer Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2506558534","media":"Insider Monkey","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506558534?lang=en_us&edition=fundamental","pubTime":"2025-01-28 07:54","pubTimestamp":1738022099,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the Top 10 AI Stocks Dominating Wall Street.In this article, we are going to take a look at where Lantern Pharma Inc.  stands against the other AI stocks.The artificial intelligence community is raving over a new reasoning model that has surprised even Silicon Valley. Developed by Chinese start-up DeepSeek, the r1 claims to match and even exceed OpenAI’s o1 by multiple benchmarks, and that too, at a fraction of the cost. A Chinese hedge-fund manager, Liang Wenfeng, has led the development of r1. Wenfeng has become the leading figure in the country’s AI initiative.While some specialists are saying that DeepSeek’s technology is a bit behind OpenAI and Google, it is still an achievement considering it has used fewer and less advanced chips. The country has also had to deal with US restrictions along the way, implying how DeepSeek either found a way around the rules or the controls weren’t stringent enough in the first place.Why are we interested in the stock","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lantern-pharma-inc-ltrn-enhances-235459932.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2756315318.SGD","LU2462157665.USD","LU1674673691.USD","LU0444971666.USD","LU0107464264.USD","LU0149725797.USD","LU1145028129.USD","IE00B1BXHZ80.USD","LU1917777945.USD","IE00BJLML261.HKD","LU0345770308.USD","LU1670628061.USD","LU0128525689.USD","LU0557290698.USD","BK4514","SGXZ51526630.SGD","LU0345770993.USD","LU2111349929.HKD","LU1267930490.SGD","LU2456880835.USD","LU1244550221.USD","LU2362541513.USD","LU0348723411.USD","LU1989764664.SGD","LU0170899867.USD","LU0130517989.USD","BK4532","LU1066051811.HKD","LU1066051498.USD","GOOGL","LU2362540622.SGD","SG9999018857.SGD","LU1043141396.HKD","IE00BQXX3F31.USD","LU0345769128.USD","BK4538","LU0096362180.USD","LU0417517546.SGD","IE00BWXC8680.SGD","LU2592432038.USD","LU1988902786.USD","LU2092627202.USD","LU0211328371.USD","LTRN","LU0215105999.USD","LU2242649171.HKD","LU2242650005.HKD","RADR","LU0476273544.USD","AAQC"],"gpt_icon":1},{"id":"2506159371","title":"Lantern Pharma : Announces Advancements in Application of Co's Radr AI Platform to Accelerate Development of Antibody-Drug Conjugates for Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2506159371","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506159371?lang=en_us&edition=fundamental","pubTime":"2025-01-27 20:57","pubTimestamp":1737982672,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nFWN3OL0GK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2506374381","title":"Lantern Pharma Unveils Innovative AI-Powered Module to Improve the Precision, Cost and Timelines of Antibody-Drug Conjugate (ADC) Development for Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2506374381","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506374381?lang=en_us&edition=fundamental","pubTime":"2025-01-27 20:55","pubTimestamp":1737982500,"startTime":"0","endTime":"0","summary":"In a peer-reviewed study published in PLOS ONE, Lantern Pharma researchers demonstrated how their AI-driven approach successfully identified 82 promising ADC targets and 290 target-indication combinations, while also validating 729 potential payload molecules from a screening of over 50,000 compounds. Notably, 22 of these targets have already been validated in clinical or preclinical settings, demonstrating the platform's ability to identify clinically relevant targets. The remaining 60 novel targets represent significant potential for new intellectual property, portfolio development of ADC candidates at Lantern Pharma and licensing opportunities with other biotech and pharma companies. The ADC module helped to characterize payload molecules with exceptional potency, exhibiting GI50 values from picomolar to 10 nM  ranges. These payload molecules can be further optimized by leveraging RADR’s comprehensive molecular features database by mapping drug-response relationships with biochemica","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lantern-pharma-unveils-innovative-ai-125500736.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4231","LTRN","ML","BK4166","BK4080","BK4139","ADC"],"gpt_icon":0},{"id":"2502362810","title":"Lantern Pharma Extends CSO’s Employment Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2502362810","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502362810?lang=en_us&edition=fundamental","pubTime":"2025-01-11 05:30","pubTimestamp":1736544648,"startTime":"0","endTime":"0","summary":"The latest update is out from Lantern Pharma ( ($LTRN) ). Lantern Pharma Inc.’s Board of Directors has approved an amendment to the employment agre...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lantern-pharma-extends-csos-employment-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lantern-pharma-extends-csos-employment-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2490004251","title":"AI-Powered Cancer Solutions: Lantern Pharma (LTRN) Launches Phase 2 Trial in Taiwan","url":"https://stock-news.laohu8.com/highlight/detail?id=2490004251","media":"Insider Monkey","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490004251?lang=en_us&edition=fundamental","pubTime":"2024-12-10 23:40","pubTimestamp":1733845241,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 AI News That Broke The Internet.In this article, we are going to take a look at where Lantern Pharma Inc. stands against the other AI stocks.Should original content contributors be paid every time large language models use their work?OpenAI CEO Sam Altman believes they should, much like Name, Image, and Likeness  deals for college athletes, he said on Wednesday at the New York Times’ DealBook Summit.“I think we do need a new [standard] for how creators are going to get rewarded. We need to find new economic models where creators can have new revenue streams”.Even though developing such an economic model will be complex, it is unclear how people getting paid for their original work could become a norm in the future even if it does. The news comes amidst ChatGPT, Altman’s AI chatbot, which has itself been under fire numerous times over the years over copyright infringement and unpermitted use of published articles.Why are we interested in the stocks ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/GkjOxHwY5KwIxtZycd1dPQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/f570aae28e1052f5a4a089428411fb02","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/GkjOxHwY5KwIxtZycd1dPQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/f570aae28e1052f5a4a089428411fb02"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ai-powered-cancer-solutions-lantern-154041958.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2490043724","title":"Lantern Pharma Announces First Patient Enrolled in Taiwan for Phase 2 Harmonic™ Clinical Trial of Lp-300 in Never-Smoker Nsclc Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2490043724","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490043724?lang=en_us&edition=fundamental","pubTime":"2024-12-09 21:15","pubTimestamp":1733750100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nTUA1SLDCZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2490221167","title":"Lantern Pharma Announces First Patient Enrolled in Taiwan for Phase 2 HARMONIC™ Clinical Trial of LP-300 in Never-Smoker NSCLC Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2490221167","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490221167?lang=en_us&edition=fundamental","pubTime":"2024-12-09 21:15","pubTimestamp":1733750100,"startTime":"0","endTime":"0","summary":"Multiple clinical trial sites across Taiwan are actively screening patients, following successful site initiation visits.Expansion into Taiwan is particularly significant as over 50% of lung cancer cases in Taiwan occur in never-smokers.DALLAS, December 09, 2024----Lantern Pharma Inc. , an artificial intelligence  company developing targeted cancer therapies using its proprietary RADR AI platform, today announced that the first patient has been enrolled and dosed in Taiwan for its Phase 2 HARMONIC clinical trial evaluating LP-300 in never-smoker patients with non-small cell lung cancer  who have progressed after receiving treatment with tyrosine kinase inhibitors .Dr. Reggie Ewesuedo, VP of Clinical Development at Lantern Pharma commented, \"The initiation of patient dosing in Taiwan demonstrates the continued momentum of our Asia expansion strategy. With active screening now occurring at multiple sites across both Japan and Taiwan, we expect to see accelerated enroll","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/l9SCzX9iYQHE4Mewz.u7Aw--~B/aD02MDA7dz0xODAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/83b8c72ad4813ad6633ea426b25c9193","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/l9SCzX9iYQHE4Mewz.u7Aw--~B/aD02MDA7dz0xODAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/83b8c72ad4813ad6633ea426b25c9193"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lantern-pharma-announces-first-patient-131500256.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4020","ML","LTRN","BK4139","BK4080","HLIT","BK4231","TK","ADC","BK4144","BK4166"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":45,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LTRN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-27","symbol":"LTRN","fiscalQuarterEnding":"2024/12","expectedEps":-0.51,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"post","actualEps":-0.54},{"market":"US","date":"2024-11-07","symbol":"LTRN","fiscalQuarterEnding":"2024/09","expectedEps":-0.56,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.42},{"market":"US","date":"2024-08-08","symbol":"LTRN","fiscalQuarterEnding":"2024/06","expectedEps":-0.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"post","actualEps":-0.46},{"market":"US","date":"2024-05-09","symbol":"LTRN","fiscalQuarterEnding":"2024/03","expectedEps":-0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-0.51},{"market":"US","date":"2024-03-18","symbol":"LTRN","fiscalQuarterEnding":"2023/12","expectedEps":-0.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1710734400000,"reportTimeType":"post","actualEps":-0.39}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LTRN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LTRN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1743825600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LTRN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LTRN","date":"2025-04-17","current":-1.811188,"percent":0.981605,"low":-49.754346,"twenty":-21.655944,"median":-4.145382,"eighty":-2.864249,"high":-1.33893,"avg":-10.808887,"sd":11.854648,"marketCap":37638690},"quantilePoints":[{"date":"2020-06-05","current":-39.359566,"twenty":-39.359566,"median":-39.359566,"eighty":-39.359566,"marketCap":96489504},{"date":"2020-06-12","current":-37.409733,"twenty":-39.359566,"median":-38.38465,"eighty":-36.899593,"marketCap":91709511},{"date":"2020-06-19","current":-33.224824,"twenty":-39.359566,"median":-36.899593,"eighty":-32.920529,"marketCap":81450258},{"date":"2020-06-26","current":-29.67408,"twenty":-38.579633,"median":-33.465813,"eighty":-30.394407,"marketCap":72745650},{"date":"2020-07-02","current":-33.300912,"twenty":-37.374225,"median":-33.123374,"eighty":-30.465455,"marketCap":81636786},{"date":"2020-07-10","current":-32.184964,"twenty":-37.165675,"median":-33.1741,"eighty":-30.790028,"marketCap":78901052},{"date":"2020-07-17","current":-33.478449,"twenty":-36.899593,"median":-32.933157,"eighty":-31.368191,"marketCap":82072016},{"date":"2020-07-24","current":-31.851447,"twenty":-36.261035,"median":-32.793662,"eighty":-31.345466,"marketCap":78083440},{"date":"2020-07-31","current":-28.842302,"twenty":-33.661132,"median":-32.540038,"eighty":-31.053798,"marketCap":76591222},{"date":"2020-08-07","current":-27.394157,"twenty":-33.453087,"median":-32.210326,"eighty":-29.81611,"marketCap":72745650},{"date":"2020-08-14","current":-25.240087,"twenty":-33.341492,"median":-32.077173,"eighty":-28.986296,"marketCap":67025480},{"date":"2020-08-21","current":-38.866924,"twenty":-33.661132,"median":-32.083514,"eighty":-28.857053,"marketCap":103211778},{"date":"2020-08-28","current":-39.967373,"twenty":-36.511038,"median":-32.223007,"eighty":-28.986296,"marketCap":106134039},{"date":"2020-09-04","current":-33.24761,"twenty":-36.899593,"median":-32.66685,"eighty":-29.267466,"marketCap":88289593},{"date":"2020-09-11","current":-45.04817,"twenty":-36.899593,"median":-32.793662,"eighty":-29.26828,"marketCap":119626181},{"date":"2020-09-18","current":-38.562545,"twenty":-38.866924,"median":-32.9712,"eighty":-29.290676,"marketCap":102403493},{"date":"2020-09-25","current":-42.987755,"twenty":-39.359566,"median":-33.224824,"eighty":-29.67408,"marketCap":114154713},{"date":"2020-10-02","current":-47.998076,"twenty":-39.382028,"median":-33.274261,"eighty":-30.384229,"marketCap":127459706},{"date":"2020-10-09","current":-47.085171,"twenty":-40.388822,"median":-33.478449,"eighty":-30.409674,"marketCap":125035473},{"date":"2020-10-16","current":-46.312516,"twenty":-41.770236,"median":-33.711344,"eighty":-30.688578,"marketCap":122983673},{"date":"2020-10-23","current":-40.974167,"twenty":-41.465857,"median":-34.558783,"eighty":-31.01829,"marketCap":108807597},{"date":"2020-10-30","current":-25.461466,"twenty":-41.442443,"median":-34.757801,"eighty":-30.688578,"marketCap":93885412},{"date":"2020-11-06","current":-27.569203,"twenty":-41.184891,"median":-33.715886,"eighty":-29.290676,"marketCap":101657383},{"date":"2020-11-13","current":-25.832427,"twenty":-40.974167,"median":-33.491805,"eighty":-28.916055,"marketCap":95253279},{"date":"2020-11-20","current":-27.063346,"twenty":-40.974167,"median":-33.300912,"eighty":-28.479745,"marketCap":99792110},{"date":"2020-11-27","current":-27.653512,"twenty":-40.974167,"median":-33.224824,"eighty":-27.569203,"marketCap":101968262},{"date":"2020-12-04","current":-25.798704,"twenty":-40.936705,"median":-33.098013,"eighty":-27.140684,"marketCap":95128928},{"date":"2020-12-11","current":-30.941582,"twenty":-40.496525,"median":-32.844388,"eighty":-26.678895,"marketCap":114092537},{"date":"2020-12-18","current":-31.44744,"twenty":-40.295167,"median":-32.692257,"eighty":-26.989154,"marketCap":115957811},{"date":"2020-12-24","current":-32.290534,"twenty":-40.229608,"median":-32.427759,"eighty":-27.12135,"marketCap":119066599},{"date":"2020-12-31","current":-32.459153,"twenty":-40.107856,"median":-32.526601,"eighty":-27.182053,"marketCap":119688357},{"date":"2021-01-08","current":-31.852125,"twenty":-39.901815,"median":-32.413226,"eighty":-27.286725,"marketCap":117450029},{"date":"2021-01-15","current":-24.179962,"twenty":-39.634897,"median":-32.24625,"eighty":-27.102015,"marketCap":89160054},{"date":"2021-01-22","current":-25.984185,"twenty":-39.377536,"median":-32.197645,"eighty":-26.635054,"marketCap":95812861},{"date":"2021-01-29","current":-25.343433,"twenty":-39.359566,"median":-32.083514,"eighty":-26.232054,"marketCap":93450182},{"date":"2021-02-05","current":-29.069912,"twenty":-39.359566,"median":-32.047625,"eighty":-26.206761,"marketCap":107191027},{"date":"2021-02-12","current":-31.127064,"twenty":-39.359566,"median":-32.037606,"eighty":-26.232054,"marketCap":114776471},{"date":"2021-02-19","current":-32.526601,"twenty":-39.359566,"median":-31.852125,"eighty":-26.279268,"marketCap":119937060},{"date":"2021-02-26","current":-29.963593,"twenty":-39.007407,"median":-31.641351,"eighty":-26.504432,"marketCap":110486343},{"date":"2021-03-05","current":-25.208537,"twenty":-38.866924,"median":-31.436771,"eighty":-26.279268,"marketCap":92952776},{"date":"2021-03-12","current":-35.863529,"twenty":-38.866924,"median":-31.442106,"eighty":-26.279268,"marketCap":211888545},{"date":"2021-03-19","current":-40.230675,"twenty":-39.007407,"median":-31.835263,"eighty":-26.504432,"marketCap":237690471},{"date":"2021-03-26","current":-35.371989,"twenty":-39.007407,"median":-31.868987,"eighty":-26.523765,"marketCap":208984432},{"date":"2021-04-01","current":-37.602825,"twenty":-38.895021,"median":-32.047625,"eighty":-26.523765,"marketCap":222164636},{"date":"2021-04-09","current":-32.381247,"twenty":-38.866924,"median":-32.083514,"eighty":-26.604703,"marketCap":191314558},{"date":"2021-04-16","current":-29.258566,"twenty":-38.866924,"median":-32.047625,"eighty":-26.665406,"marketCap":172865170},{"date":"2021-04-23","current":-31.321428,"twenty":-38.698345,"median":-31.852125,"eighty":-26.689012,"marketCap":185052947},{"date":"2021-04-30","current":-28.406926,"twenty":-38.581276,"median":-31.656371,"eighty":-26.894727,"marketCap":167833519},{"date":"2021-05-07","current":-22.155216,"twenty":-38.248499,"median":-31.436771,"eighty":-26.523765,"marketCap":174654202},{"date":"2021-05-14","current":-18.353937,"twenty":-37.716257,"median":-31.351316,"eighty":-26.216879,"marketCap":144687924},{"date":"2021-05-21","current":-20.552438,"twenty":-37.508972,"median":-31.195828,"eighty":-26.149432,"marketCap":162019167},{"date":"2021-05-28","current":-21.446023,"twenty":-37.424888,"median":-31.101771,"eighty":-26.017909,"marketCap":169063478},{"date":"2021-06-04","current":-21.524034,"twenty":-37.366783,"median":-31.022091,"eighty":-25.930125,"marketCap":169678458},{"date":"2021-06-11","current":-22.098481,"twenty":-37.274577,"median":-30.941582,"eighty":-25.818938,"marketCap":174206944},{"date":"2021-06-18","current":-21.403471,"twenty":-37.227708,"median":-30.614831,"eighty":-25.738872,"marketCap":168728035},{"date":"2021-06-25","current":-21.644597,"twenty":-37.029643,"median":-30.431937,"eighty":-25.62334,"marketCap":170628881},{"date":"2021-07-02","current":-20.708461,"twenty":-36.899593,"median":-30.384684,"eighty":-25.476146,"marketCap":163249126},{"date":"2021-07-09","current":-20.33968,"twenty":-36.890456,"median":-30.352795,"eighty":-25.221157,"marketCap":160341949},{"date":"2021-07-16","current":-18.439041,"twenty":-36.864694,"median":-30.182797,"eighty":-24.793735,"marketCap":145358811},{"date":"2021-07-23","current":-19.531199,"twenty":-36.581934,"median":-30.078022,"eighty":-22.705551,"marketCap":153968525},{"date":"2021-07-30","current":-15.403585,"twenty":-36.105763,"median":-29.947911,"eighty":-22.138196,"marketCap":144274103},{"date":"2021-08-06","current":-16.346905,"twenty":-35.960314,"median":-29.731278,"eighty":-21.726863,"marketCap":153109493},{"date":"2021-08-13","current":-15.045362,"twenty":-35.897559,"median":-29.424012,"eighty":-21.566586,"marketCap":140918891},{"date":"2021-08-20","current":-13.636352,"twenty":-35.725617,"median":-29.281466,"eighty":-21.409145,"marketCap":127721725},{"date":"2021-08-27","current":-16.788713,"twenty":-35.490294,"median":-29.267262,"eighty":-21.278653,"marketCap":157247588},{"date":"2021-09-03","current":-16.955884,"twenty":-35.417362,"median":-29.086774,"eighty":-21.074405,"marketCap":158813353},{"date":"2021-09-10","current":-16.10809,"twenty":-35.363879,"median":-29.010896,"eighty":-20.824769,"marketCap":150872686},{"date":"2021-09-17","current":-14.125923,"twenty":-35.256515,"median":-28.916055,"eighty":-20.685767,"marketCap":132307181},{"date":"2021-09-24","current":-14.531909,"twenty":-34.881047,"median":-28.820644,"eighty":-20.50705,"marketCap":136109754},{"date":"2021-10-01","current":-12.776617,"twenty":-34.574126,"median":-28.611675,"eighty":-20.294292,"marketCap":119669217},{"date":"2021-10-08","current":-13.182603,"twenty":-34.544735,"median":-28.462884,"eighty":-19.760978,"marketCap":123471790},{"date":"2021-10-15","current":-11.952704,"twenty":-34.44971,"median":-27.952719,"eighty":-19.576588,"marketCap":111952230},{"date":"2021-10-22","current":-12.036289,"twenty":-34.275477,"median":-27.705292,"eighty":-19.20497,"marketCap":112735113},{"date":"2021-10-29","current":-12.191519,"twenty":-34.173387,"median":-27.569203,"eighty":-18.370958,"marketCap":114189038},{"date":"2021-11-05","current":-9.842875,"twenty":-33.997191,"median":-27.187561,"eighty":-17.888706,"marketCap":115346279},{"date":"2021-11-12","current":-9.308247,"twenty":-33.714069,"median":-26.945313,"eighty":-16.795878,"marketCap":109081108},{"date":"2021-11-19","current":-8.582681,"twenty":-33.666475,"median":-26.65023,"eighty":-16.497358,"marketCap":100578375},{"date":"2021-11-26","current":-8.554041,"twenty":-33.505162,"median":-26.523765,"eighty":-16.346905,"marketCap":100242741},{"date":"2021-12-03","current":-7.2843,"twenty":-33.504591,"median":-26.279268,"eighty":-15.928978,"marketCap":85362959},{"date":"2021-12-10","current":-7.704365,"twenty":-33.478449,"median":-26.194958,"eighty":-15.475229,"marketCap":90285594},{"date":"2021-12-17","current":-7.341582,"twenty":-33.351637,"median":-26.152804,"eighty":-15.105066,"marketCap":86034228},{"date":"2021-12-23","current":-6.978799,"twenty":-33.311057,"median":-26.11908,"eighty":-14.656093,"marketCap":81782861},{"date":"2021-12-31","current":-7.618442,"twenty":-33.25827,"median":-26.017909,"eighty":-14.381456,"marketCap":89278691},{"date":"2022-01-07","current":-6.711485,"twenty":-33.229381,"median":-25.950292,"eighty":-14.202344,"marketCap":78650276},{"date":"2022-01-14","current":-6.940611,"twenty":-33.224824,"median":-25.874582,"eighty":-13.674562,"marketCap":81335349},{"date":"2022-01-21","current":-5.842715,"twenty":-33.19439,"median":-25.815565,"eighty":-13.464405,"marketCap":68469372},{"date":"2022-01-28","current":-6.033654,"twenty":-33.082795,"median":-25.798704,"eighty":-13.165886,"marketCap":70706933},{"date":"2022-02-04","current":-6.434624,"twenty":-33.00801,"median":-25.714394,"eighty":-12.7599,"marketCap":75405812},{"date":"2022-02-11","current":-6.596922,"twenty":-32.951779,"median":-25.630085,"eighty":-12.36182,"marketCap":77307739},{"date":"2022-02-18","current":-6.377343,"twenty":-32.874823,"median":-25.571068,"eighty":-12.213013,"marketCap":74734544},{"date":"2022-02-25","current":-6.100482,"twenty":-32.824098,"median":-25.473699,"eighty":-12.067335,"marketCap":71490080},{"date":"2022-03-04","current":-5.346275,"twenty":-32.763263,"median":-25.240087,"eighty":-11.589705,"marketCap":62651713},{"date":"2022-03-11","current":-5.964441,"twenty":-32.697339,"median":-25.054193,"eighty":-9.89061,"marketCap":73738551},{"date":"2022-03-18","current":-6.06908,"twenty":-32.63773,"median":-24.78699,"eighty":-9.669121,"marketCap":75032210},{"date":"2022-03-25","current":-6.226039,"twenty":-32.56707,"median":-23.472542,"eighty":-9.273878,"marketCap":76972698},{"date":"2022-04-01","current":-6.304518,"twenty":-32.507746,"median":-22.665836,"eighty":-8.714429,"marketCap":77942942},{"date":"2022-04-08","current":-6.11268,"twenty":-32.47134,"median":-22.141033,"eighty":-8.309639,"marketCap":75571234},{"date":"2022-04-14","current":-5.99932,"twenty":-32.455781,"median":-21.970826,"eighty":-8.080514,"marketCap":74169771},{"date":"2022-04-22","current":-6.01676,"twenty":-32.436479,"median":-21.687148,"eighty":-7.763555,"marketCap":74385381},{"date":"2022-04-29","current":-5.22141,"twenty":-32.411349,"median":-21.637505,"eighty":-7.50388,"marketCap":64552444},{"date":"2022-05-06","current":-4.746858,"twenty":-32.399323,"median":-21.446023,"eighty":-7.295756,"marketCap":66610324},{"date":"2022-05-13","current":-4.515304,"twenty":-32.363104,"median":-21.410563,"eighty":-7.230838,"marketCap":63361039},{"date":"2022-05-20","current":-4.631081,"twenty":-32.283789,"median":-21.375103,"eighty":-7.138233,"marketCap":64985682},{"date":"2022-05-27","current":-4.330061,"twenty":-32.252586,"median":-21.21908,"eighty":-7.009349,"marketCap":60761612},{"date":"2022-06-03","current":-4.413883,"twenty":-32.235688,"median":-21.112702,"eighty":-6.91197,"marketCap":61937853},{"date":"2022-06-10","current":-4.160254,"twenty":-32.210326,"median":-21.03469,"eighty":-6.740126,"marketCap":58378804},{"date":"2022-06-17","current":-3.755035,"twenty":-32.184964,"median":-20.786473,"eighty":-6.654203,"marketCap":52692557},{"date":"2022-06-24","current":-3.890108,"twenty":-32.161504,"median":-20.708461,"eighty":-6.500434,"marketCap":54587972},{"date":"2022-07-01","current":-4.337779,"twenty":-32.115171,"median":-20.665909,"eighty":-6.423168,"marketCap":60869922},{"date":"2022-07-08","current":-4.468993,"twenty":-32.094937,"median":-20.552438,"eighty":-6.333427,"marketCap":62711183},{"date":"2022-07-15","current":-4.160254,"twenty":-32.085385,"median":-20.424784,"eighty":-6.243603,"marketCap":58378804},{"date":"2022-07-22","current":-3.897827,"twenty":-32.075905,"median":-20.282945,"eighty":-6.231271,"marketCap":54696282},{"date":"2022-07-29","current":-3.959574,"twenty":-32.062919,"median":-19.775871,"eighty":-6.154674,"marketCap":55562758},{"date":"2022-08-05","current":-4.214284,"twenty":-32.045621,"median":-19.71559,"eighty":-6.100482,"marketCap":59136970},{"date":"2022-08-12","current":-4.266648,"twenty":-31.946552,"median":-19.580843,"eighty":-6.074312,"marketCap":69155596},{"date":"2022-08-19","current":-3.742088,"twenty":-31.865615,"median":-19.531199,"eighty":-6.039432,"marketCap":60653303},{"date":"2022-08-26","current":-3.802295,"twenty":-31.851718,"median":-19.048947,"eighty":-6.008464,"marketCap":61629171},{"date":"2022-09-02","current":-3.474796,"twenty":-31.841737,"median":-18.439041,"eighty":-5.953459,"marketCap":56320924},{"date":"2022-09-09","current":-3.563002,"twenty":-31.692149,"median":-18.311386,"eighty":-5.923279,"marketCap":57750609},{"date":"2022-09-16","current":-3.347832,"twenty":-31.465463,"median":-17.956789,"eighty":-5.846534,"marketCap":54263044},{"date":"2022-09-23","current":-3.16741,"twenty":-31.443172,"median":-16.955884,"eighty":-5.814926,"marketCap":51338688},{"date":"2022-09-30","current":-3.194139,"twenty":-31.421553,"median":-16.681247,"eighty":-5.711562,"marketCap":51771926},{"date":"2022-10-07","current":-3.374561,"twenty":-31.391233,"median":-16.526016,"eighty":-5.645613,"marketCap":54696282},{"date":"2022-10-14","current":-3.214186,"twenty":-31.357051,"median":-16.382728,"eighty":-5.408473,"marketCap":52096855},{"date":"2022-10-21","current":-3.133998,"twenty":-31.322155,"median":-16.299142,"eighty":-5.121538,"marketCap":50797141},{"date":"2022-10-28","current":-2.873389,"twenty":-31.271188,"median":-15.95883,"eighty":-4.705178,"marketCap":46573072},{"date":"2022-11-04","current":-2.873389,"twenty":-31.195301,"median":-15.582696,"eighty":-4.573964,"marketCap":46573072},{"date":"2022-11-11","current":-3.53139,"twenty":-31.167532,"median":-15.439407,"eighty":-4.510673,"marketCap":50919517},{"date":"2022-11-18","current":-4.005756,"twenty":-31.10683,"median":-15.140888,"eighty":-4.48443,"marketCap":57759452},{"date":"2022-11-25","current":-3.802456,"twenty":-31.066361,"median":-15.045362,"eighty":-4.468993,"marketCap":54828052},{"date":"2022-12-02","current":-3.840104,"twenty":-31.024372,"median":-14.627435,"eighty":-4.414099,"marketCap":55370904},{"date":"2022-12-09","current":-3.960578,"twenty":-31.016438,"median":-14.424442,"eighty":-4.387177,"marketCap":57108030},{"date":"2022-12-16","current":-4.322,"twenty":-30.99554,"median":-14.299065,"eighty":-4.362479,"marketCap":62319409},{"date":"2022-12-23","current":-4.231644,"twenty":-30.890981,"median":-14.221449,"eighty":-4.331605,"marketCap":61016564},{"date":"2022-12-30","current":-4.547888,"twenty":-30.688578,"median":-13.958752,"eighty":-4.322,"marketCap":65576521},{"date":"2023-01-06","current":-4.178937,"twenty":-30.664948,"median":-13.684115,"eighty":-4.2961,"marketCap":60256572},{"date":"2023-01-13","current":-4.12623,"twenty":-30.588305,"median":-13.582618,"eighty":-4.228632,"marketCap":59496579},{"date":"2023-01-20","current":-3.9154,"twenty":-30.498766,"median":-13.278129,"eighty":-4.214284,"marketCap":56456608},{"date":"2023-01-27","current":-4.005756,"twenty":-30.439507,"median":-13.170662,"eighty":-4.193895,"marketCap":57759452},{"date":"2023-02-03","current":-4.299411,"twenty":-30.418579,"median":-12.901995,"eighty":-4.200454,"marketCap":61993698},{"date":"2023-02-10","current":-4.465062,"twenty":-30.394954,"median":-12.752735,"eighty":-4.206043,"marketCap":64382247},{"date":"2023-02-17","current":-4.103641,"twenty":-30.384593,"median":-12.472746,"eighty":-4.181621,"marketCap":59170868},{"date":"2023-02-24","current":-3.9154,"twenty":-30.377849,"median":-12.340779,"eighty":-4.153392,"marketCap":56456608},{"date":"2023-03-03","current":-4.171407,"twenty":-30.355891,"median":-12.227342,"eighty":-4.141289,"marketCap":60148001},{"date":"2023-03-10","current":-3.23766,"twenty":-30.329741,"median":-12.125845,"eighty":-4.12749,"marketCap":46684186},{"date":"2023-03-17","current":-3.576568,"twenty":-30.26415,"median":-12.036289,"eighty":-4.099206,"marketCap":51570940},{"date":"2023-03-24","current":-3.437568,"twenty":-30.176471,"median":-11.648214,"eighty":-4.081052,"marketCap":49019535},{"date":"2023-03-31","current":-3.677398,"twenty":-30.136702,"median":-11.200436,"eighty":-4.068388,"marketCap":52439503},{"date":"2023-04-06","current":-3.761149,"twenty":-30.085978,"median":-9.852422,"eighty":-4.059969,"marketCap":53633777},{"date":"2023-04-14","current":-3.844899,"twenty":-30.04453,"median":-9.709218,"eighty":-4.007326,"marketCap":54828052},{"date":"2023-04-21","current":-3.738308,"twenty":-29.963593,"median":-9.594655,"eighty":-3.990697,"marketCap":53308066},{"date":"2023-04-28","current":-3.631716,"twenty":-29.947911,"median":-9.308247,"eighty":-3.990448,"marketCap":51788080},{"date":"2023-05-05","current":-3.806831,"twenty":-29.920953,"median":-9.126856,"eighty":-3.962604,"marketCap":54285200},{"date":"2023-05-12","current":-4.178189,"twenty":-29.788476,"median":-8.668604,"eighty":-3.962604,"marketCap":58519445},{"date":"2023-05-19","current":-3.643318,"twenty":-29.67408,"median":-8.491986,"eighty":-3.960578,"marketCap":51028088},{"date":"2023-05-26","current":-3.674325,"twenty":-29.474597,"median":-8.219898,"eighty":-3.959574,"marketCap":51462369},{"date":"2023-06-02","current":-4.116175,"twenty":-29.434129,"median":-8.057601,"eighty":-3.958337,"marketCap":57650882},{"date":"2023-06-09","current":-4.255706,"twenty":-29.397638,"median":-7.857115,"eighty":-3.95332,"marketCap":59605149},{"date":"2023-06-16","current":-4.581279,"twenty":-29.31075,"median":-7.704365,"eighty":-3.958337,"marketCap":64165106},{"date":"2023-06-23","current":-4.13943,"twenty":-29.279623,"median":-7.618442,"eighty":-3.959574,"marketCap":57976593},{"date":"2023-06-30","current":-3.992147,"twenty":-29.270665,"median":-7.456145,"eighty":-3.959976,"marketCap":55913756},{"date":"2023-07-07","current":-3.96114,"twenty":-29.268076,"median":-7.341582,"eighty":-3.960578,"marketCap":55479474},{"date":"2023-07-14","current":-4.030905,"twenty":-29.265523,"median":-7.269979,"eighty":-3.959775,"marketCap":56456608},{"date":"2023-07-21","current":-3.643318,"twenty":-29.224208,"median":-7.227019,"eighty":-3.953116,"marketCap":51028088},{"date":"2023-07-28","current":-3.488284,"twenty":-29.086774,"median":-7.181671,"eighty":-3.941001,"marketCap":48856680},{"date":"2023-08-04","current":-3.658822,"twenty":-29.083402,"median":-7.083815,"eighty":-3.9154,"marketCap":51245228},{"date":"2023-08-11","current":-3.80683,"twenty":-29.046305,"median":-7.012213,"eighty":-3.903079,"marketCap":54285200},{"date":"2023-08-18","current":-3.285114,"twenty":-28.94887,"median":-6.940611,"eighty":-3.893814,"marketCap":46845562},{"date":"2023-08-25","current":-3.582375,"twenty":-28.93268,"median":-6.768766,"eighty":-3.88239,"marketCap":51084488},{"date":"2023-09-01","current":-3.445178,"twenty":-28.906358,"median":-6.740126,"eighty":-3.874911,"marketCap":49128060},{"date":"2023-09-08","current":-3.361335,"twenty":-28.867569,"median":-6.701938,"eighty":-3.859234,"marketCap":47932466},{"date":"2023-09-15","current":-3.193649,"twenty":-28.842302,"median":-6.625563,"eighty":-3.847634,"marketCap":45541277},{"date":"2023-09-22","current":-2.8659,"twenty":-28.816312,"median":-6.511,"eighty":-3.842981,"marketCap":40867590},{"date":"2023-09-29","current":-2.629616,"twenty":-28.728847,"median":-6.484585,"eighty":-3.822188,"marketCap":37498188},{"date":"2023-10-06","current":-2.416198,"twenty":-28.668005,"median":-6.453718,"eighty":-3.818334,"marketCap":34454856},{"date":"2023-10-13","current":-2.431442,"twenty":-28.608896,"median":-6.372569,"eighty":-3.808049,"marketCap":34672237},{"date":"2023-10-20","current":-2.355221,"twenty":-28.574172,"median":-6.310514,"eighty":-3.80683,"marketCap":33585333},{"date":"2023-10-27","current":-2.103693,"twenty":-28.526959,"median":-6.304518,"eighty":-3.802392,"marketCap":29998550},{"date":"2023-11-03","current":-2.088448,"twenty":-28.459511,"median":-6.243583,"eighty":-3.796462,"marketCap":29781169},{"date":"2023-11-10","current":-2.674822,"twenty":-28.422564,"median":-6.234759,"eighty":-3.786034,"marketCap":40541519},{"date":"2023-11-17","current":-2.760875,"twenty":-28.134402,"median":-6.215769,"eighty":-3.775032,"marketCap":41845804},{"date":"2023-11-24","current":-2.891389,"twenty":-27.886995,"median":-6.18163,"eighty":-3.764808,"marketCap":43823969},{"date":"2023-12-01","current":-2.832586,"twenty":-27.775873,"median":-6.121399,"eighty":-3.757481,"marketCap":42932708},{"date":"2023-12-08","current":-2.696335,"twenty":-27.715647,"median":-6.100482,"eighty":-3.742088,"marketCap":40867590},{"date":"2023-12-15","current":-2.976008,"twenty":-27.619788,"median":-6.08652,"eighty":-3.728574,"marketCap":45106516},{"date":"2023-12-22","current":-2.92581,"twenty":-27.569203,"median":-6.060914,"eighty":-3.710855,"marketCap":44345683},{"date":"2023-12-29","current":-3.148115,"twenty":-27.569203,"median":-6.04292,"eighty":-3.682077,"marketCap":47715085},{"date":"2024-01-05","current":-2.997521,"twenty":-27.464175,"median":-6.03856,"eighty":-3.676169,"marketCap":45432587},{"date":"2024-01-12","current":-2.897126,"twenty":-27.286725,"median":-6.01676,"eighty":-3.652498,"marketCap":43910921},{"date":"2024-01-19","current":-2.753704,"twenty":-27.193069,"median":-5.99932,"eighty":-3.636357,"marketCap":41737113},{"date":"2024-01-26","current":-3.004693,"twenty":-27.12135,"median":-5.960859,"eighty":-3.595258,"marketCap":45541277},{"date":"2024-02-02","current":-3.033377,"twenty":-27.016133,"median":-5.947001,"eighty":-3.581467,"marketCap":45976039},{"date":"2024-02-09","current":-2.976008,"twenty":-26.844141,"median":-5.899997,"eighty":-3.557152,"marketCap":45106516},{"date":"2024-02-16","current":-2.875613,"twenty":-26.68564,"median":-5.852262,"eighty":-3.548697,"marketCap":43584850},{"date":"2024-02-23","current":-2.775217,"twenty":-26.665406,"median":-5.842715,"eighty":-3.544265,"marketCap":42063184},{"date":"2024-03-01","current":-3.449301,"twenty":-26.604703,"median":-5.815138,"eighty":-3.535733,"marketCap":52280082},{"date":"2024-03-08","current":-4.768784,"twenty":-26.523765,"median":-5.720282,"eighty":-3.534794,"marketCap":72279116},{"date":"2024-03-15","current":-5.270761,"twenty":-26.519898,"median":-5.711562,"eighty":-3.534822,"marketCap":79887444},{"date":"2024-03-22","current":-6.076744,"twenty":-26.459399,"median":-5.720282,"eighty":-3.535733,"marketCap":96994155},{"date":"2024-03-28","current":-6.581457,"twenty":-26.279268,"median":-5.814075,"eighty":-3.53892,"marketCap":105050148},{"date":"2024-04-05","current":-4.858703,"twenty":-26.220251,"median":-5.815247,"eighty":-3.540353,"marketCap":77552359},{"date":"2024-04-12","current":-4.488581,"twenty":-26.203389,"median":-5.798762,"eighty":-3.544265,"marketCap":71644631},{"date":"2024-04-19","current":-3.882925,"twenty":-26.186527,"median":-5.711562,"eighty":-3.544265,"marketCap":61977439},{"date":"2024-04-26","current":-3.67431,"twenty":-26.152804,"median":-5.676682,"eighty":-3.547966,"marketCap":58647629},{"date":"2024-05-03","current":-3.700511,"twenty":-26.152804,"median":-5.592109,"eighty":-3.544265,"marketCap":59065839},{"date":"2024-05-10","current":-4.590252,"twenty":-26.135942,"median":-5.449964,"eighty":-3.547966,"marketCap":73267462},{"date":"2024-05-17","current":-3.767359,"twenty":-26.11908,"median":-5.375831,"eighty":-3.548301,"marketCap":66059062},{"date":"2024-05-24","current":-3.822581,"twenty":-26.102218,"median":-5.270761,"eighty":-3.54929,"marketCap":67027355},{"date":"2024-05-31","current":-3.865532,"twenty":-26.034771,"median":-5.222097,"eighty":-3.551368,"marketCap":67780471},{"date":"2024-06-07","current":-3.564879,"twenty":-26.017909,"median":-5.215024,"eighty":-3.554841,"marketCap":62508657},{"date":"2024-06-14","current":-3.337856,"twenty":-25.997675,"median":-5.047678,"eighty":-3.548167,"marketCap":58527899},{"date":"2024-06-21","current":-2.724279,"twenty":-25.970628,"median":-4.921059,"eighty":-3.541918,"marketCap":47769094},{"date":"2024-06-28","current":-2.785637,"twenty":-25.957071,"median":-4.879965,"eighty":-3.538123,"marketCap":48844974},{"date":"2024-07-05","current":-2.632243,"twenty":-25.920042,"median":-4.773258,"eighty":-3.534794,"marketCap":46155273},{"date":"2024-07-12","current":-2.577021,"twenty":-25.889758,"median":-4.677392,"eighty":-3.524417,"marketCap":45186981},{"date":"2024-07-15","current":-2.712008,"twenty":-25.886385,"median":-4.672877,"eighty":-3.516764,"marketCap":47553918},{"date":"2024-08-02","current":-2.49112,"twenty":-25.883013,"median":-4.668362,"eighty":-3.513777,"marketCap":43680748},{"date":"2024-08-09","current":-2.595428,"twenty":-25.866151,"median":-4.656049,"eighty":-3.486212,"marketCap":45509745},{"date":"2024-08-16","current":-2.602067,"twenty":-25.832427,"median":-4.631081,"eighty":-3.47183,"marketCap":46180670},{"date":"2024-08-23","current":-2.559609,"twenty":-25.798704,"median":-4.597393,"eighty":-3.454749,"marketCap":45427139},{"date":"2024-08-30","current":-2.450431,"twenty":-25.798704,"median":-4.580911,"eighty":-3.437634,"marketCap":43489489},{"date":"2024-09-06","current":-2.122898,"twenty":-25.798704,"median":-4.569333,"eighty":-3.425531,"marketCap":37676537},{"date":"2024-09-13","current":-2.298796,"twenty":-25.763894,"median":-4.550892,"eighty":-3.410889,"marketCap":40798307},{"date":"2024-09-20","current":-2.468628,"twenty":-25.722553,"median":-4.532829,"eighty":-3.385253,"marketCap":43812430},{"date":"2024-09-27","current":-2.329123,"twenty":-25.714394,"median":-4.518517,"eighty":-3.364857,"marketCap":41336544},{"date":"2024-10-04","current":-2.183553,"twenty":-25.660436,"median":-4.507586,"eighty":-3.349575,"marketCap":38753010},{"date":"2024-10-11","current":-2.056179,"twenty":-25.633457,"median":-4.492149,"eighty":-3.345103,"marketCap":36492417},{"date":"2024-10-18","current":-2.056179,"twenty":-25.616595,"median":-4.48443,"eighty":-3.321099,"marketCap":36492417},{"date":"2024-10-25","current":-2.092571,"twenty":-25.586244,"median":-4.468993,"eighty":-3.300188,"marketCap":37138301},{"date":"2024-10-31","current":-1.977328,"twenty":-25.569382,"median":-4.468993,"eighty":-3.280799,"marketCap":35093003},{"date":"2024-11-08","current":-2.074375,"twenty":-25.516614,"median":-4.453556,"eighty":-3.262859,"marketCap":36815359},{"date":"2024-11-15","current":-1.967789,"twenty":-25.471252,"median":-4.414423,"eighty":-3.237626,"marketCap":37568890},{"date":"2024-11-22","current":-1.666407,"twenty":-25.390646,"median":-4.399527,"eighty":-3.221873,"marketCap":31814938},{"date":"2024-11-29","current":-1.813277,"twenty":-25.302095,"median":-4.397296,"eighty":-3.196812,"marketCap":34618967},{"date":"2024-12-06","current":-1.977093,"twenty":-25.227467,"median":-4.376411,"eighty":-3.174092,"marketCap":37746537},{"date":"2024-12-13","current":-2.050528,"twenty":-25.147834,"median":-4.367817,"eighty":-3.139645,"marketCap":39148551},{"date":"2024-12-20","current":-1.813277,"twenty":-25.05471,"median":-4.348356,"eighty":-3.094682,"marketCap":34618967},{"date":"2024-12-27","current":-1.988391,"twenty":-25.002055,"median":-4.337419,"eighty":-3.077838,"marketCap":37962232},{"date":"2025-01-03","current":-1.864117,"twenty":-24.803852,"median":-4.33356,"eighty":-3.053811,"marketCap":35589592},{"date":"2025-01-10","current":-2.214345,"twenty":-24.790362,"median":-4.324687,"eighty":-3.033377,"marketCap":42276122},{"date":"2025-01-17","current":-2.033582,"twenty":-24.530689,"median":-4.300154,"eighty":-3.018391,"marketCap":38825010},{"date":"2025-01-24","current":-2.355566,"twenty":-24.294623,"median":-4.299187,"eighty":-3.008996,"marketCap":44972303},{"date":"2025-01-31","current":-2.717091,"twenty":-23.331059,"median":-4.280286,"eighty":-3.000867,"marketCap":51874527},{"date":"2025-02-07","current":-2.993884,"twenty":-22.705551,"median":-4.269116,"eighty":-2.987482,"marketCap":57159042},{"date":"2025-02-14","current":-2.728389,"twenty":-22.665836,"median":-4.259678,"eighty":-2.976008,"marketCap":52090221},{"date":"2025-02-21","current":-2.445947,"twenty":-22.484282,"median":-4.247217,"eighty":-2.968837,"marketCap":46697859},{"date":"2025-02-28","current":-2.253886,"twenty":-22.189258,"median":-4.231644,"eighty":-2.952498,"marketCap":43031052},{"date":"2025-03-07","current":-2.197398,"twenty":-22.143869,"median":-4.214284,"eighty":-2.93585,"marketCap":41952580},{"date":"2025-03-14","current":-2.112666,"twenty":-22.115502,"median":-4.209055,"eighty":-2.92581,"marketCap":40334871},{"date":"2025-03-21","current":-2.101368,"twenty":-21.996357,"median":-4.192657,"eighty":-2.899677,"marketCap":40119177},{"date":"2025-03-28","current":-2.101368,"twenty":-21.820477,"median":-4.18341,"eighty":-2.890529,"marketCap":40119177},{"date":"2025-04-04","current":-1.686637,"twenty":-21.746721,"median":-4.174798,"eighty":-2.875613,"marketCap":35050356},{"date":"2025-04-11","current":-1.577654,"twenty":-21.675801,"median":-4.160254,"eighty":-2.868896,"marketCap":32785564},{"date":"2025-04-17","current":-1.811188,"twenty":-21.655944,"median":-4.145382,"eighty":-2.864249,"marketCap":37638690}],"updateTime":1745273914929}}}